These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 10426727

  • 1. Drug cuts deaths from heart failure by a third.
    Gottlieb S.
    BMJ; 1999 Jul 31; 319(7205):276. PubMed ID: 10426727
    [No Abstract] [Full Text] [Related]

  • 2. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec 31; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction].
    MMW Fortschr Med; 2003 Oct 30; 145(44):42-3. PubMed ID: 14655506
    [No Abstract] [Full Text] [Related]

  • 5. What's old is new again. Spironolactone and heart failure.
    Lock M, Chun R.
    Can Fam Physician; 1999 Nov 30; 45():2621-2. PubMed ID: 10587769
    [No Abstract] [Full Text] [Related]

  • 6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of heart failure after myocardial infarction. With eplerenone a new course].
    MMW Fortschr Med; 2004 Oct 21; 146(43):58-9. PubMed ID: 15559524
    [No Abstract] [Full Text] [Related]

  • 8. Effects of beta-blocker therapy in severe chronic heart failure.
    Negut C.
    N Engl J Med; 2001 Sep 27; 345(13):998; author reply 998-9. PubMed ID: 11575300
    [No Abstract] [Full Text] [Related]

  • 9. Spironolactone in left-sided heart failure: how does it fit in?
    Margo KL, Luttermoser G, Shaughnessy AF.
    Am Fam Physician; 2001 Oct 15; 64(8):1393-8. PubMed ID: 11681781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].
    Opasich C.
    Ital Heart J Suppl; 2000 Mar 15; 1(3):425-6. PubMed ID: 10815276
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Medical treatment of heart failure: old facts in new lights].
    Angehrn W.
    Schweiz Med Wochenschr; 2000 Jan 11; 130(1-2):25-7. PubMed ID: 10670042
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Value of diuretics and aldosterone antagonists in the treatment of heart failure].
    Schwinger RH.
    Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S40-7. PubMed ID: 10535046
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.